{"id":"W4321132006","doi":"10.33590/emjdermatol/10314045","title":"Latest Highlights from Guselkumab in Psoriasis from EADV 2019","year":2019,"lang":"en","type":"article","venue":"EMJ Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Tolerability; Clinical trial; Dermatology; Secukinumab; Ustekinumab; Venereology; Internal medicine; Adverse effect; Psoriatic arthritis; Adalimumab; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005712688,0.0003471605,0.0007465227,0.0002144972,0.00008313267,0.00001584603,0.0003917934,0.0007359217,0.00441677],"category_scores_gemma":[0.00002759207,0.0003089061,0.0001433231,0.0001857055,0.00009736308,0.0001423701,0.0001142613,0.0002637763,0.02756881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006001371,"about_ca_system_score_gemma":0.0000790188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00360364,"about_ca_topic_score_gemma":0.001015657,"domain_scores_codex":[0.9978241,0.000393638,0.0004931698,0.0006434749,0.00004456997,0.0006010378],"domain_scores_gemma":[0.9985595,0.0005719671,0.0001569904,0.0006376771,0.00003438293,0.00003947069],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001265777,0.001028828,0.7729385,0.0000251618,0.001916685,0.001122169,0.002920974,0.0000116387,0.1393368,0.003988081,0.06635969,0.009085586],"study_design_scores_gemma":[0.01456953,0.0001647562,0.4838218,0.00009434247,0.0003429893,0.0004280932,0.000395817,0.00001342201,0.2306246,0.002715238,0.265795,0.001034439],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9840822,0.007491552,0.000007889249,0.001387224,0.003861462,0.0003115556,0.0003150808,0.0001422521,0.002400816],"genre_scores_gemma":[0.9950954,0.0002578745,0.0001809708,0.0003184418,0.00007936348,0.00004103316,0.001633667,0.0000352276,0.002358077],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2891167,"threshold_uncertainty_score":0.9999363,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00900181662433231,"score_gpt":0.215701605695829,"score_spread":0.2066997890714967,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}